Oesophageal and gastrooesophageal reflux: What is the relationship?

Gut

Volumn 53, Issue 8, 2004, Pages 1064-1065

  Lagergren, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CHRONIC DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; ENDOSCOPIC SURGERY; ESOPHAGUS CANCER; GASTROESOPHAGEAL REFLUX; HUMAN; NOTE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ADENOCARCINOMA; ESOPHAGUS TUMOR;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; GASTROESOPHAGEAL REFLUX; HUMANS;

EID: 4143119283     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.038471     Document Type: Note

References (10)

1. Chow WH, Finkle WD, McLaughlin JK, et al. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995;274:474-7.
2. Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31.
3. Farrow DC, Vaughan TL, Sweeney C, et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000;11:231-8.
4. Ye W, Chow WH, Lagergren J, et al. Risk of adenocarcinomas of the oesophagus and gastric cardia in patients with gastrooesophageal reflux diseases and after antireflux surgery. A nationwide cohort study in Sweden. Gastroenterology 2001;121:1286-93.
5. Wu AH, Tseng CC, Bernstein L Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. Cancer 2003;98:940-8.
6. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk. Gastroenterology 1984;87:927-33.
7. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barett's) esophagus. N Engl J Med 1985;314:857-8.
8. Van Der Veen AH, Dees J, Blankenstein JD, et al. Adenocarcinoma in Barrel's esophagus: an overrated risk. Gut 1989;10:16-18.
9. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:214-15.
10. Solaymani-Dodaran M, Lagan RFA, West J, et al. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004;53:1070-74.